Diabetes drug metformin tested as asthma treatment for overweight patients
NCT ID NCT06273072
First seen Jan 28, 2026 · Last updated May 02, 2026 · Updated 10 times
Summary
This study tests whether metformin, a common diabetes medicine, can improve asthma control in overweight or obese adults whose asthma is not well-controlled by their current inhalers. About 100 participants will take either metformin or a placebo for 24 weeks and have their asthma symptoms, attacks, and medication adherence monitored. The goal is to see if metformin can reduce inflammation and improve breathing in this specific group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor College of Medicine
RECRUITINGHouston, Texas, 77030, United States
Contact
-
Johns Hopkins University
RECRUITINGBaltimore, Maryland, 21224, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.